Novel PET agent effectively detects multiple cancers, identifies patients for targeted therapies

Close Up Scientist using microscope in laboratory room while making medical testing and research

A new molecular imaging radiotracer can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies. In the largest medical study of its kind, researchers found that 68Ga-PentixaFor demonstrated high image contrast in hematologic malignancies, small cell lung cancer, and adrenocortical neoplasms.

These early Black Friday sex toy deals will have you buzzing with excitement

Previous article

Alcohol misuse is an overlooked risk factor for severe COVID-19, according to a review of evidence

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations